| Chen Z., Sandercock P., Pan H., Counsell C., Collins R., Liu L., . (2000) Indications
for early aspirin use in acute ischemic stroke: a combined analysis of
40000 randomized patients from the chinese acute stroke trial and the
international stroke trial. On behalf of the CAST and IST collaborative
groups. Stroke 31: 1240–1249. , Google Scholar |
| Cotter G., Shemesh E., Zehavi M., Dinur I., Rudnick A., Milo O., . (2004) Lack of aspirin effect: aspirin resistance or resistance to taking aspirin? Am Heart J 147: 293–300. , Google Scholar |
| Cuisset T., Frere C., Poyet R., Quilici J., Gaborit B., Bali L., . (2010) Clopidogrel
response: head-to-head comparison of different platelet assays to
identify clopidogrel non responder patients after coronary stenting. Arch Cardiovasc Dis 103: 39–45. , Google Scholar |
| Dorsam R., Kunapuli S. (2004) Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113: 340–345. , Google Scholar |
| Eikelboom J., Hankey G. (2003) Aspirin resistance: a new independent predictor of vascular events? J Am Coll Cardiol 41: 966–968. , Google Scholar |
| Feher G., Feher A., Pusch G., Lupkovics G., Szapary L., Papp E., . (2009) The genetics of antiplatelet drug resistance. Clin Genet 75:1–18. , Google Scholar |
| Floyd C., Ferro A. (2015) Antiplatelet drug resistance: molecular insights and clinical implications. Prostaglandins Other Lipid Mediat 120: 21–27. , Google Scholar |
| Frelinger A.III, Furman M., Linden M., Li Y., Fox M., Barnard M., . (2006) Residual
arachidonic acid-induced platelet activation via an adenosine
diphosphate-dependent but cyclooxygenase-1- and
cyclooxygenase-2-independent pathway: a 700-patient study of aspirin
resistance. Circulation 113: 2888–2896. , Google Scholar |
| Frey U., Aral N., Muller N., Siffert W. (2003) Cooperative effect of GNB3 825C > T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregation. Thromb Res 109: 279–286. , Google Scholar |
| Goodman T., Ferro A., Sharma P. (2008) Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol 66: 222–232. , Google Scholar |
| Goodman T., Sharma P., Ferro A. (2007) The genetics of aspirin resistance. Int J Clin Pract 61: 826–834. , Google Scholar |
| Grinshtein Y., Kosinova A., Grinshtein I. (2013) Aspirin resistance candidate genes and their association with the risk of fatal cardiovascular events. Ter Arkh 85: 95–100. , Google Scholar |
| Halushka M., Walker L., Halushka P. (2003) Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther 73: 122–130. , Google Scholar |
| Han S., Kim S., Lee J., Chu C., Yang J., Shin H., . (2007) A new subtype classification of ischemic stroke based on treatment and etiologic mechanism. Eur Neurol 57: 96–102. , Google Scholar |
| International Stroke Trial Collaborative Group. (1997) The
International Stroke Trial (IST): a randomised trial of aspirin,
subcutaneous heparin, both, or neither among 19435 patients with acute
ischaemic stroke. Lancet 349: 1569–1581. , Google Scholar |
| Kernan W., Ovbiagele B., Black H., Bravata D., Chimowitz M., Ezekowitz M., . (2014) Guidelines
for the prevention of stroke in patients with stroke and transient
ischemic attack: a guideline for healthcare professionals from the
American Heart Association/American Stroke Association. Stroke 45: 2160–2236. , Google Scholar |
| Kunicki T., Williams S., Nugent D., Harrison P., Segal H., Syed A., . (2009) Lack
of association between aspirin responsiveness and seven candidate gene
haplotypes in patients with symptomatic vascular disease. Thromb Haemost 101: 123–133. , Google Scholar |
| Lev E., Patel R., Guthikonda S., Lopez D., Bray P., Kleiman N., . (2007) Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel. Thromb Res 119: 355–360. , Google Scholar |
| Li Q., Chen B., Ozdemir V., Ji W., Mao Y., Wang L., . (2007) Frequency
of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese
population and association with attenuated response to aspirin. Pharmacogenomics 8: 577–586. , Google Scholar |
| Lou X., Chen G., Yan L., Ma J., Zhu J., Elston R., . (2007) A
generalized combinatorial approach for detecting gene-by-gene and
gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet 80: 1125–1137. , Google Scholar |
| Marquardt L., Ruf A., Mansmann U., Winter R., Schuler M., Buggle F., . (2002) Course of platelet activation markers after ischemic stroke. Stroke 33: 2570–2574. , Google Scholar |
| Nakahata N. (2008) Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 118: 18–35. , Google Scholar |
| Niu W., Qi Y. (2012) Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis. Heart 98: 1483–1491. , Google Scholar |
| Ruggeri Z. (2002) Platelets in atherothrombosis. Nat Med 8: 1227–1234. , Google Scholar |
| Schwartz K., Schwartz D., Ghosheh K., Reeves M., Barber K., DeFranco A., . (2005) Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 95: 973–975. , Google Scholar |
| Sharma V., Kaul S., Al-Hazzani A., Alshatwi A., Jyothy A., Munshi A., . (2013) Association of COX-2 rs20417 with aspirin resistance. J Thromb Thrombolysis 35: 95–99. , Google Scholar |
| Sirotkina O., Khaspekova S., Zabotina A., Shimanova Y., Mazurov A. (2007) Effects
of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro
polymorphism on platelet aggregation and sensitivity to glycoprotein
IIb-IIIa antagonists. Platelets 18: 506–514. , Google Scholar |
| Storey R. (2006) Biology and pharmacology of the platelet P2Y12 receptor. Curr Pharm Des 12: 1255–1259. , Google Scholar |
| Wang C., Yi X., Zhang B., Liao D., Lin J., Chi L., . (2015) Clopidogrel
plus aspirin prevents early neurologic deterioration and improves
6-Month outcome in patients with acute large artery atherosclerosis
stroke. Clin Appl Thromb Hemost 21: 453–461. , Google Scholar Abstract |
| Wang S., Zhao H. (2003) Sample size needed to detect gene-gene interactions using association designs. Am J Epidemiol 158: 899–914. , Google Scholar |
| Wang Y., Wu D., Liao X., Zhang W., Zhao X., Wang Y., . (2007) Burden of stroke in China. Int J Stroke 2: 211–213. , Google Scholar Abstract |
| Yi X., Chi W., Wang C., Zhang B., Lin J. (2015a) Low-molecular-weight
heparin or dual antiplatelet therapy is more effective than aspirin
alone in preventing early neurological deterioration and improving the
6-month outcome in ischemic stroke patients. J Clin Neurol 11:57–65. , Google Scholar |
| Yi X., Liao D., Fu X., Zhang B., Wang C. (2015b) Interaction
among CYP2C8, EPHX2, and CYP4A11 gene variants significantly increases
the risk for ischemic stroke in Chinese populations. J Atheroscler Thromb 22: 1148–1157. , Google Scholar |
| Yi X., Zhou Q., Lin J., Chi L. (2013a) Aspirin resistance in Chinese stroke patients increased the rate of recurrent stroke and other vascular events. Int J Stroke 8: 535–539. , Google Scholar Abstract |
| Yi X., Zhou Q., Lin J., Chi L., Han Z. (2013b) Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. J Atheroscler Thromb 20: 65–72. , Google Scholar |
| Zhao D., Liu J., Wang W., Zeng Z., Cheng J., Liu J., . (2008) Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 39: 1668–1674. , Google Scholar |
No comments:
Post a Comment